IRIS
LIUZZI, Grazia Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.611
AS - Asia 2.656
EU - Europa 1.981
SA - Sud America 622
AF - Africa 166
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.045
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.527
SG - Singapore 1.175
CN - Cina 751
BR - Brasile 553
HK - Hong Kong 394
SE - Svezia 388
IT - Italia 311
RU - Federazione Russa 251
UA - Ucraina 248
DE - Germania 244
FI - Finlandia 159
FR - Francia 124
VN - Vietnam 121
CI - Costa d'Avorio 118
GB - Regno Unito 105
IN - India 54
CA - Canada 47
AR - Argentina 28
BE - Belgio 26
BD - Bangladesh 24
ZA - Sudafrica 24
NL - Olanda 22
IE - Irlanda 21
MX - Messico 20
PL - Polonia 19
JP - Giappone 16
IQ - Iraq 15
TR - Turchia 15
ES - Italia 14
ID - Indonesia 14
AT - Austria 11
IR - Iran 11
VE - Venezuela 11
CZ - Repubblica Ceca 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
LT - Lituania 7
SA - Arabia Saudita 7
EC - Ecuador 6
HN - Honduras 6
JO - Giordania 6
CO - Colombia 5
MA - Marocco 5
MY - Malesia 5
PE - Perù 5
PY - Paraguay 5
TN - Tunisia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
DZ - Algeria 4
LB - Libano 4
AL - Albania 3
CL - Cile 3
CR - Costa Rica 3
ET - Etiopia 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
UY - Uruguay 3
BH - Bahrain 2
BO - Bolivia 2
EG - Egitto 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KR - Corea 2
NP - Nepal 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MW - Malawi 1
MZ - Mozambico 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.045
Salva come PNG Salva come JPEG
Città #
Woodbridge 672
Fairfield 605
Chandler 604
Ashburn 574
Jacksonville 563
Singapore 562
Houston 412
Hong Kong 393
Ann Arbor 333
Nyköping 315
Wilmington 245
Seattle 241
Cambridge 227
Beijing 217
Lawrence 127
Roxbury 126
Abidjan 118
Nanjing 110
Marseille 97
New York 93
Bari 88
Boardman 84
Des Moines 79
Los Angeles 66
Inglewood 56
Dallas 51
São Paulo 49
Ho Chi Minh City 45
Munich 43
Princeton 39
Jiaxing 37
Santa Clara 36
Brooklyn 35
Shenyang 34
Buffalo 29
Nanchang 29
Turku 28
Hanoi 27
Moscow 27
San Diego 27
Brussels 25
Changsha 25
Guangzhou 25
Hebei 24
Dublin 21
London 21
Shanghai 21
Belo Horizonte 19
Chicago 19
Denver 18
Tianjin 17
Warsaw 17
Leawood 16
Leverano 16
Amsterdam 15
Dearborn 15
Rio de Janeiro 15
San Francisco 15
Spongano 15
Toronto 15
Dhaka 14
Wuhan 14
Auburn Hills 13
Jakarta 13
Tokyo 13
Curitiba 12
Monmouth Junction 12
Rome 12
Chennai 11
Falkenstein 11
Falls Church 11
Johannesburg 11
Augusta 10
Da Nang 10
Helsinki 10
Montreal 10
Salvador 10
Atlanta 9
Campinas 9
Frankfurt am Main 9
Grottaglie 9
Mumbai 9
Norwalk 9
Paris 9
Porto Alegre 9
Pune 9
Stockholm 9
Zhengzhou 9
Boston 8
Jinan 8
Nuremberg 8
Orem 8
Ardabil 7
Brasília 7
Council Bluffs 7
Hefei 7
Kunming 7
Milan 7
Osasco 7
Palermo 7
Totale 8.301
Salva come PNG Salva come JPEG
Nome #
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 166
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 165
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta 161
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 152
FAD synthesis and degradation in the nucleus create a local flavin cofactor pool 144
A thermodynamic and structural study of myelin basic protein in lipid membrane models 137
Biological variations in a long-term ex situ cultivation: a Mediterranean demosponge as model system 136
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 133
A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains 129
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 128
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 126
Autoimmune Myelofibrosis: report of three cases and review of the literature 122
BLOOD MMP-9 AND SICAM-1 AS MARKERS OF RIFN-B TREATMENT EFFICACY IN RELAPSING-REMITTING MS 120
Native Myelin Proteins and Myelin Assembly in the Central Nervous System 119
Aquaporin-4-containing astrocytes sustain a temperature- and mercury-insensitive swelling in vitro 119
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 116
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis 116
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 115
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 115
Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies 114
Identification of water-soluble proteases in myelin preparations 112
Anti-endothelial cell antibodies (AECA) in a patient wiyh Takayasu’s arteritis. In: Pathogenesis and immunotherapy of autoimmune diseases. Final program and abstract book 112
Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases 112
Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex 112
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 112
T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors 110
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes 110
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 110
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 109
Recombinant arabidopsis HSP70 sustains cell survival and metastatic potential of breast cancer cells 107
New Diagnostic and Therapeutic Options for the Treatment of Multiple Sclerosis 106
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 106
Marine pharmacology: Therapeutic targeting of matrix metalloproteinases in neuroinflammation 106
Different recognition by clostripain of myelin basic protein in the lipid-free and lipid-bound forms 104
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 103
Crystals of P2 myelin protein in lipid-bound form 101
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 101
Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex 101
May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. 100
Aids dementia complex. On the relationship between HIV-1 infection, immune-mediated response and myelin damage in the brain 99
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. 99
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 98
Purification of bovine P2 myelin protein with bound lipids 98
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA 98
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 96
Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunction 93
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 92
The different forms of PNS myelin P0 protein within and outside lipid rafts 91
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes 91
null 91
null 90
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 90
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 88
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 88
Autoimmune bone marrow fibrosis: a distinct clinicopathological entity 87
null 87
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 87
Laminar order within Langmuir-Blodgett multilayers from phospholipid and myelin basic protein: a neutron reflectivity study 86
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 86
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 85
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 84
Aumento dell’attività della Gelatinasi B nel liquor di pazienti HIV-positivi con malattie neurologiche del Sistema Nervoso Centrale 83
Meccanismo molecolare di “Swelling” in astrociti in coltura 83
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 82
Detection of serum levels and intrathecal synthesis of matrix metallo proteinase-9 in relapsing-remitting multiple sclerosis 82
Ruolo delle proteasi nell’induzione e nella patogenesi della sclerosi multipla 82
Decreased levels of serum Gelatinase B in MS patients treated with rIFN-beta-1b 82
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis 82
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 81
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form 81
Increased Gelatinase B Activity in the CSF of Patients with HIV-Associated Neurological Diseases 80
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 80
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 80
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 80
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 79
Determinazione degli Anticorpi Liquorali Anti-MBP per la Diagnosi di Danno Mielinico in Pazienti con AIDS Dementia Complex 78
Meccanismi di demielinizzazione in pazienti con neuroAIDS 78
CEREBROSPINAL FLUID MARKERS FOR THE MONITORING OF AIDS DEMENTIA COMPLEX SEVERITY: USEFULNESS OF ANTI-MYELIN BASIC PROTEIN ANTIBODY DETECTION 78
Demyelination and cerebral toxoplasmosis in HIV-infected patients 77
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 77
Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice 77
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 77
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 76
Intrathecal synthesis of matrix metalloproteinase (MMP)-9 in patients with relapsing-remitting (RR) multiple sclerosis (MS) 75
CNS Myelin Proteins in Lipid-Bound Native Form as Tools for Study, Detection and Treatment of Multiple Sclerosis 75
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 73
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 72
Follow-up of myelin damage in HIV-associated cryptococcal meningitis. First evidence of anti-myelin basic protein antibodies in the cerebrospinal fluid 72
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 72
CHANGES OF SERUM SOLUBLE ICAM-1 AND MATRIX METALLOPROTEINASE-9 DURING INTERFERON BETA-1B TREATMENT IN RR MS 72
Il ruolo delle proteasi nell’induzione e nella patogenesi della Sclerosi Multipla 72
Inhibition of myelin-cleaving proteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. 71
Structure-based design of multitargeting ChEs-MAO B inhibitors based on phenyl ring bioisosteres: AChE/BChE selectivity switch and drug-like characterization 70
Matrix Metalloproteinases in CNS Inflammation. 70
Extracting and purifying R-phycoerythrin from Mediterranean red algae Corallina elongata Ellis & Solander 70
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 70
Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV 69
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 69
Plant Lectins Regulate the Release of Matrix Metalloproteases in Rat Glial Cell Cultures 69
Decreased levels of serum gelatinase B in MS patients during the treatment with rIFN-beta-1b 69
Totale 9.636
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.505
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021629 0 0 0 0 0 36 103 67 112 154 121 36
2021/2022805 24 116 6 24 33 51 32 47 57 55 158 202
2022/20231.675 197 138 106 170 216 213 13 187 347 36 25 27
2023/2024551 44 97 23 120 46 118 7 6 6 14 10 60
2024/20252.239 130 41 197 60 66 134 183 181 96 104 297 750
2025/20262.445 678 269 300 493 515 190 0 0 0 0 0 0
Totale 12.232